Lila Ash had long suffered from depression, and no treatment seemed to help. The few times she felt better, she had taken psychedelic drugs with friends. And yet, when her psychiatrist prescribed ketamine, she hesitated. She considered it a party drug, not a serious medicine. Eventually, though, she reached the point where she was willing to try it.
Listen to ASPET President, Dr. Carol Beck, give updates on ASPET 2025 abstract submissions, our expanded list of countries eligible for reduced membership rates and more!
September is a unique month that celebrates two overlapping, though certainly important, parts of the ASPET community: National Postdoc Appreciation Week (NPAW) and Peer Review Week.
A Conversation with ASPET’s Young Scientists Committee Chair Saranya Radhakrishnan, PhD
Updates from some of our outstanding ASPET members.
This month The Pharmacologist features two new policy briefs written by participants of the 2024 ASPET Washington Fellows program. These topics present compelling arguments for policy improvements on an issue of personal importance to each Fellow. The policy briefs below discuss the importance of understanding polysubstance use and accessible treatments for opioid use disorder in El Paso, Texas.
A showcase of early-career scientists—what drives them and why pharmacology is important to them.
The 37th Annual Meeting of the Great Lakes Chapter of the American Society for Pharmacology and Experimental Therapeutics (ASPET-GLC) was held at Rosalind Franklin University of Medicine and Science (RFUMS) in North Chicago on June 21, 2024. More than 165 pharmacologists, neuroscientists, biologists, clinicians and students attended the meeting. They represented academia and the pharmaceutical industry in the Midwest, including 24 ASPET members.
According to the Society for Scholarly Publishing, Peer Review Week is a globally recognized, annual, community-led, virtual event that celebrates the indispensable role of peer review in upholding research quality.
